Melatonin supplementation to treat the metabolic syndrome: a randomized controlled trial

BACKGROUND: Supplemental melatonin may ameliorate metabolic syndrome (MetS) components, but data from placebo-controlled trials are lacking. METHODS: We conducted a double-blind, placebo-controlled, crossover, Phase II randomized pilot clinical trial to estimate the effects of melatonin supplementat...

Descripción completa

Detalles Bibliográficos
Autores principales: Goyal, Abhinav, Terry, Paul D, Superak, Hillary M, Nell-Dybdahl, Christine L, Chowdhury, Ritam, Phillips, Lawrence S, Kutner, Michael H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4416300/
https://www.ncbi.nlm.nih.gov/pubmed/25937837
http://dx.doi.org/10.1186/1758-5996-6-124

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4416300/
https://www.ncbi.nlm.nih.gov/pubmed/25937837
http://dx.doi.org/10.1186/1758-5996-6-124

Ejemplares similares